Study Design of a Phase III, Randomized, Placebo-Controlled Trial of Nintedanib in Children and Adolescents with Clinically Significant Fibrosing Interstitial Lung Disease (ILD)

被引：0
|
作者：
Young, L. [1 ]
Brown, K. K. [2 ]
Griese, M. [3 ]
Deutsch, G. [4 ]
Warburton, D. [5 ]
DeBoer, E. [6 ]
Cunningham, S. [7 ]
Clement, A. F. [8 ]
Schwerk, N. [9 ]
Flaherty, K. R. [10 ]
Voss, F. [11 ]
Schmid, U. [11 ]
Schlenker-Herceg, R. [12 ]
Verri, D. [13 ]
Stowasser, S. [14 ]
Clerisme-Beaty, E. M. [14 ]
Deterding, R. R. [6 ]
机构：
[1] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Munich, Germany
[4] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[6] Univ Colorado Denver, Sect Pediat Pulm & Sleep Med, Dept Pediat, Aurora, CO USA
[7] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[8] Sorbonne Univ, Trousseau Hosp, AP HP, Pediat Pulm Dept, Paris, France
[9] Hannover Med Sch, Clin Pediat Pulmonol Allergol & Neonatol, Hannover, Germany
[10] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[11] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[12] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[13] Boehringer Ingelheim Italia SpA, Milan, Italy
[14] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1495
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
    Deterding, Robin
    Griese, Matthias
    Deutsch, Gail
    Warburton, David
    DeBoer, Emily M.
    Cunningham, Steven
    Clement, Annick
    Schwerk, Nicolaus
    Flaherty, Kevin R.
    Brown, Kevin K.
    Voss, Florian
    Schmid, Ulrike
    Schlenker-Herceg, Rozsa
    Verri, Daniela
    Dumistracel, Mihaela
    Schiwek, Marilisa
    Stowasser, Susanne
    Tetzlaff, Kay
    Clerisme-Beaty, Emmanuelle
    Young, Lisa R.
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [2] Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD trial
    Deterding, R.
    Young, L. R.
    Deboer, E. M.
    Warburton, D.
    Cunningham, S.
    Schwerk, N.
    Flaherty, K. R.
    Brown, K. K.
    Dumistracel, M.
    Erhardt, E.
    Bertulis, J.
    Gahlemann, M.
    Stowasser, S.
    Griese, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD trial
    Matthias, Griese
    Robin, Deterding
    Lisa, Young R.
    Emily, DeBoer M.
    David, Warburton
    Steven, Cunningham
    Nicolaus, Schwerk
    Kevin, Flaherty R.
    Kevin, Brown K.
    Mihaela, Dumistracel
    Elvira, Erhardt
    Julia, Bertulis
    Martina, Gahlemann
    Susanne, Stowasser
    KLINISCHE PADIATRIE, 2023, 235 (02): : 125 - 125
  • [4] Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD* trial**
    Griese, Autoren M.
    Deterding, R.
    Young, L.
    DeBoer, E.
    Warburton, D.
    Cunningham, S.
    Schwerk, N.
    Flaherty, K.
    Brown, K.
    Dumistracel, M.
    Erhardt, E.
    Bertulis, J.
    Gahlemann, M.
    Stowasser, S.
    PNEUMOLOGIE, 2023, 77 : S53 - S53
  • [5] Design of Phase III, Randomized, Placebo-Controlled Trials of BI 1015550 in Patients with Progressive Fibrosing Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis (FIBRONEER-ILD / -IPF)
    Kreuter, M.
    Maher, T.
    Azuma, A.
    Cottin, V
    Assassi, S.
    Hoffmann-Vold, A.
    Martinez, F.
    Oldham, J.
    Valenzuela, C.
    Wijsenbeek, M.
    Liu, Y.
    Wachtlin, D.
    Stowasser, S.
    Zoz, D.
    Richeldi, L.
    PNEUMOLOGIE, 2023, 77 : S93 - S94
  • [6] Circulating biomarkers in children and adolescents with fibrosing interstitial lung disease (ILD)
    Deterding, Robin
    Brown, Kevin K.
    Cunningham, Steven
    Deboer, Emily M.
    Griese, Matthias
    Schwerk, Nicolaus
    Young, Lisa R.
    Ittrich, Carina
    Schlange, Thomas
    Gahlemann, Martina
    Warburton, David
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
    Maher, Toby M.
    Corte, Tamera J.
    Fischer, Aryeh
    Kreuter, Michael
    Lederer, David J.
    Molina-Molina, Maria
    Axmann, Judit
    Kirchgaessler, Klaus-Uwe
    Cottin, Vincent
    BMJ OPEN RESPIRATORY RESEARCH, 2018, 5 (01):
  • [8] Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
    Distler, O.
    Brown, K. K.
    Distler, J. H. W.
    Assassi, S.
    Maher, T. M.
    Cottin, V.
    Varga, J.
    Coeck, C.
    Gahlemann, M.
    Sauter, W.
    Schmidt, H.
    Highland, K. B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) : S75 - S81
  • [9] Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial
    Volkmann, Elizabeth H.
    McMahan, Zsuzsanna
    Smith, Vanessa
    Jouneau, Stephane
    Miede, Corinna
    Alves, Margarida L.
    Herrick, Ariane
    ARTHRITIS CARE & RESEARCH, 2023, 75 (12) : 2501 - 2507
  • [10] Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
    Rimner, Andreas
    Moore, Zachary R.
    Lobaugh, Stephanie
    Geyer, Alexander
    Gelblum, Daphna Y.
    Abdulnour, Raja-Elie E.
    Shepherd, Annemarie F.
    Shaverdian, Narek
    Wu, Abraham J.
    Cuaron, John
    Chaft, Jamie E.
    Zauderer, Marjorie G.
    Eng, Juliana
    Riely, Gregory J.
    Rudin, Charles M.
    Vander Els, Nicholas
    Chawla, Mohit
    McCune, Megan
    Li, Henry
    Jones, David R.
    Sopka, Dennis M.
    Simone, Charles B.
    Mak, Raymond
    Weinhouse, Gerald L.
    Liao, Zhongxing
    Gomez, Daniel R.
    Zhang, Zhigang
    Paik, Paul K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (05): : 1091 - 1099
12345